Skip to content
  • Reports
  • Podcast Subscribe
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Liver disease

Liver disease

ADVERTISEMENT
News and Trends

Companies unite to bolster diagnostics for cancer and liver disease

Two companies set on making improvements for those with lung cancer, non-alcoholic fatty liver disease…

By Liza Laws
June 28, 2022 - 2 minutes
News and Trends

Eiger BioPharmaceuticals presents liver study data

Eiger BioPharmaceuticals, Inc., a commercial-stage biopharma company focused on the development of innovative therapies to…

By Jim Cornall
June 28, 2022 - 4 minutes
In Depth

Is a Treatment for NASH Finally on the Horizon?

Despite several high-profile trial failures in the field, multiple players are getting close to the…

By Clara Rodríguez Fernández
March 2, 2022 - 6 minutes
News and Trends

Engitix Builds Liver Disease Pipeline with Series A and Drug Collaboration

With the close of its Series A round at €48M ($54M), the tissue models company…

By Jonathan Smith
January 19, 2022 - 3 minutes
Sponsored by Medpace

Infographic: The Key Role of Imaging in Clinical Trials

Medical imaging techniques, such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound have…

By Maya Chergova
January 26, 2021 - 2 minutes
News and Trends

German Biotech Raises €11M to Regenerate Liver Damage

  Biotech company HepaRegeniX has raised a Series B round that will allow its first…

By Clara Rodríguez Fernández
January 21, 2020 - 2 minutes
News and Trends

Update: Cell Therapy Biotech Raises €47M to Fund NASH Clinical Trial

Update (17/12/2019): Promethera has increased the total raised in its Series D round to €47.2M…

By Jonathan Smith
December 17, 2019 - 2 minutes
Sponsored

Treating Liver Diseases: Is This Preclinical Model the Solution?

Liver diseases are on the rise. Although many drug candidates are being developed, preclinical toxicity,…

By Larissa Warneck-Silvestrin
December 4, 2019 - 6 minutes
Sponsored

Can This Cell Therapy Help Fight the NASH Epidemic?

Nonalcoholic steatohepatitis (NASH) is the most severe form of nonalcoholic fatty liver disease (NAFLD) and…

By Larissa Warneck-Silvestrin
November 4, 2019 - 7 minutes
More News!

€15M to Take Swiss Biotech’s Liver Cirrhosis Treatment to Phase II

Versantis has raised a Series B of €14.6M (CHF 16M) to advance its treatment for…

By Jonathan Smith
September 18, 2019 - 3 minutes
News and Trends

Drug for Autoimmune Liver Disease Yields Mixed Results in Hard-to-Treat Patients

Developed by the French biotech Genkyotex, a first-in-class treatment for the liver disease primary biliary…

By Jonathan Smith
May 2, 2019 - 2 minutes
News and Trends

Swiss Biotech Raises €11M to Develop Treatments for Liver Fibrosis

Founded in March this year, Alentis Therapeutics has bagged a Series A round of €11.1M…

By Jonathan Smith
April 30, 2019 - 2 minutes
  • 1
  • 2
  • 3
  • Next Page »
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Gene therapy Synthetic biology
    Labiotech.eu
    • Log In

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast